FDA
approval
· 2020-08-20
FDA Approved: FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (CIPLA USA INC.)
Summary
FDA approved a supplemental application for the combination drug fosinopril sodium and hydrochlorothiazide submitted by CIPLA USA INC.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE (FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE)